Latest News
Caribou Biosciences, Inc.
- Caribou Biosciences Discontinues Development for Vispa-cel & CB-011 CAR-T Cell Therapy Programs
- Caribou Biosciences, biotech co-founded by Jennifer Doudna, is shutting down
- CAR-T biotech Caribou makes ‘heartbreaking’ call to shrink headcount, halt pipeline
- Caribou to halt CAR-T work, lay off staff amid ‘challenging’ funding climate
- Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road
- Caribou Biosciences Plunges 35% After Halting Cell Therapy Pipeline and Launching Strategic Review
- Doudna’s CAR T biotech Caribou to end R&D activities, slash staff as financing freezes up
- Caribou Drops Vispa-Cel, CB-011 CAR-T Programs, Eyes Sale
- Caribou Biosciences stock plunges 40% on halt of CAR-T programs
- Caribou Biosciences to halt CAR-T programs, explore strategic alternatives
- Caribou Biosciences to Evaluate Strategic Alternatives
- Caribou Biosciences to Discontinue CAR-T Programs, Opens Strategic Review
Headlines from the last 30 days, linking to the original publishers. See all market news →